Abstract

Background and Aims: Children with asthma are susceptible to the effects of ambient air pollution, including increased symptoms and lung inflammation. Industrial emissions are an important source of air pollution in many areas. Oil refinery emissions are of particular concern as they comprise a complex mixture of organic and inorganic pollutants. We examined associations between fractional exhaled nitric oxide (FeNO), an indicator of airway inflammation, and exposure to oil refinery and traffic emissions on the health of children with asthma in Montreal, Canada. Methods: We recruited 69 children (age 8-13 years) with a physician diagnosis of asthma from schools and an asthma clinic. Subjects participated in the panel study for 10 consecutive days between October 2009 and April 2010. We measured personal exposures to sulphur dioxide (SO2) using Ogawa passive samplers (Ogawa & Company, Pompano Beach, FL, USA) and fine particulate matter (PM2.5) using Harvard Personal Environmental Monitors (HPEM, BGI, MA, USA) and continuously using the personal DataRAM (pDR-1200, MIE Inc, Bedford, MA). Filters were also analyzed for metals associated with oil refinery emissions. We recorded online FeNO daily using the NIOX MINO monitor (Aerocrine, Solna, Sweden) and collected participants’ reports on health, medication use, and activities. Linear mixed-effects regression models with autoregressive correlation structure were used to estimate the association between FeNO and pollutant exposure. Results: The geometric mean of FeNO was 20.9 ppb (geometric standard deviation: 2.2). Mean (SD) personal exposure to PM2.5 was 9.5 (13.4) µg/m3, while for SO2 it was 0.81 (3.21) ppb. Preliminary models indicate that an increase of 10 µg/m3 in previous 8-hour personal exposure to PM2.5 was associated with a 1% (95% CI: 0.1-2.0%) increase in FeNO, adjusted for corticosteroid use, age and sex. Conclusions: Preliminary results indicate an association between personal exposures to PM2.5 and increased airway inflammation in children with asthma.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.